Identifying optimal adjuvant treatment for individual patients: young age is still an issue?
- PMID: 19940009
- DOI: 10.1093/annonc/mdp545
Identifying optimal adjuvant treatment for individual patients: young age is still an issue?
Comment on
-
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.Ann Oncol. 2009 Aug;20(8):1319-29. doi: 10.1093/annonc/mdp322. Epub 2009 Jun 17. Ann Oncol. 2009. PMID: 19535820 Free PMC article.
Similar articles
-
Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy.Breast Cancer Res Treat. 2010 Apr;120(2):437-9. doi: 10.1007/s10549-010-0787-1. Epub 2010 Feb 17. Breast Cancer Res Treat. 2010. PMID: 20162380 No abstract available.
-
The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.Clin Adv Hematol Oncol. 2008 Aug;6(8):573-4. Clin Adv Hematol Oncol. 2008. PMID: 18820598 Review. No abstract available.
-
[Adjuvant chemotherapy in primary carcinoma of the breast].Zentralbl Gynakol. 2003 Sep;125(9):322-6. doi: 10.1055/s-2003-43038. Zentralbl Gynakol. 2003. PMID: 14569511 Review. German.
-
Chemotherapy for older women with node-positive breast cancer.CMAJ. 2001 Sep 4;165(5):525, 527. CMAJ. 2001. PMID: 11563200 Free PMC article. No abstract available.
-
Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update).CMAJ. 2001 Jan 23;164(2):213. CMAJ. 2001. PMID: 11332317 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical